13F-HR: Pfizer Discloses Q2 2025 Investment Holdings
Holdings Report
Pfizer Inc. has filed its Form 13F-HR, revealing its institutional investment holdings totaling over $576 million as of June 30, 2025.
Summary
- Pfizer Inc. filed its Form 13F-HR for the quarter ended June 30, 2025.
- The report details 24 distinct institutional investment holdings.
- The total value of these holdings is $576,193,012.
- All holdings of Pfizer Inc. are reported in this single report, with no other included managers.
Sentiment
Score: 5
Explanation: A Form 13F-HR is a routine regulatory disclosure of investment holdings, providing factual data without expressing positive or negative sentiment regarding the reporting entity's performance.
Future Outlook
NA
Industry Context
The filing provides a snapshot of Pfizer's investment portfolio, primarily consisting of holdings in various biotechnology and pharmaceutical companies. This indicates Pfizer's strategic investments within its broader industry, potentially supporting innovation or future partnerships.
Comparison to Industry Standards
- This filing is a standard regulatory disclosure for institutional investment managers.
- The specific holdings reflect Pfizer's investment strategy within the biotech and pharmaceutical sectors, including companies like Biohaven Ltd., Biontech SE, and Arvinas Inc., without providing performance metrics for direct comparison to industry investment returns.
Stakeholder Impact
- Shareholders gain transparency into Pfizer's institutional investment portfolio, which can inform their understanding of the company's broader strategic interests and capital allocation in the biotech and pharmaceutical sectors.
Key Dates
| Date | Description |
|---|---|
| 06-30-2025 | End of the calendar quarter for which the report is filed. |
| 08-11-2025 | Date the report was signed and filed. |
Keywords
Pfizer, 13F, Holdings, Investment, Portfolio, SEC Filing, Institutional Investor, Pharmaceutical, Biotech, Q2 2025
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.